Latest Articles

This article explores how stem cell therapies and organoid models are advancing Alzheimer’s research. It highlights progress in microglial replacement, patient-derived brain models and the use of AI to accelerate discovery.

Technology Networks spoke with Dr. Alice Fleerackers about how reputation-driven shortcuts in science journalism shape public trust, sideline diverse voices and why fostering critical research literacy could transform how science is reported.

Explore types of therapeutic proteins, design strategies and the production methods used in treating cancer, autoimmune diseases and more.

Dr. Michael Traxlmayr detailed how engineered protein “building blocks” can give CAR T cells new abilities, from drug-controlled activation to tumor-specific targeting, offering a blueprint for safer, more precise cancer immunotherapy.

In this fourth installment of The Gut Microbiome and Cancer: A Miniseries, we explore how harnessing microbial communities – both natural and synthetic – could help shape the future of precision cancer therapy.

This article explores how automation, AI and genetic tools are transforming cell line development, streamlining cloning, improving productivity and enabling faster biologic drug production.

For decades, drug discovery has focused on inhibiting enzymes to treat disease. Yet vast swathes of the proteome remain “undruggable” by traditional approaches. Molecular glues offer a way to remove harmful proteins from cells entirely.

Discover how automation is transforming protein purification, reducing costs and accelerating biopharma drug development.

Discover essential antibody purification methods, from affinity chromatography to ion exchange chromatography, for research and therapeutic applications.

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in modern treatments.